Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Neurochem Res ; 45(10): 2456-2473, 2020 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-32779097

RESUMO

Neuroinflammation is a predisposing factor for the development of cognitive impairment and dementia. Among the new molecules that are currently being studied, ellagic acid (EA) has stood out for its neuroprotective properties. The present study investigated the effects of ellagic acid in the object recognition test, oxidative stress, cholinergic neurotransmission, glial cell expression, and phosphorylated Tau protein expression. For this, 32 male Wistar rats received an intraperitoneal (IP) application of lipopolysaccharides (LPS) at a dose of 250 µg/kg or 0.9% saline solution (SAL) for 8 days. Two hours after the IP injections, the animals received 100 mg/kg of EA or SAL via intragastric gavage. Behavioral parameters (open field test and object recognition) were performed on days 5, 6, and 7 of the experimental periods. The results showed that the treatment with EA in the LPS group was able to inhibit cognitive impairment, modulate the immune system response by significantly reducing glial cell expression, attenuating phosphorylated Tau and oxidative damage with consequent improvement in the antioxidant system, as well as preventing the increase of acetylcholinesterase activity. Thus, the neuroprotective effects of EA and its therapeutic potential in cognitive disorders secondary to neuroinflammation were demonstrated.


Assuntos
Disfunção Cognitiva/tratamento farmacológico , Ácido Elágico/uso terapêutico , Inflamação/tratamento farmacológico , Fármacos Neuroprotetores/uso terapêutico , Acetilcolinesterase/metabolismo , Animais , Peso Corporal/efeitos dos fármacos , Córtex Cerebral/efeitos dos fármacos , Disfunção Cognitiva/induzido quimicamente , Hipocampo/efeitos dos fármacos , Inflamação/induzido quimicamente , Lipopolissacarídeos , Masculino , Teste de Campo Aberto/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Fosforilação/efeitos dos fármacos , Ratos Wistar , Proteínas tau/química , Proteínas tau/metabolismo
2.
Mol Cell Biochem ; 425(1-2): 181-189, 2017 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-27896593

RESUMO

The objective of this study was to evaluate the effects of different protocols (P1, P2, and P3) of boldenone undecylenate (BU) and stanozolol (ST) on markers of liver and kidney function and variables of oxidative stress in these organs. For this, 54 male Wistar rats were divided into nine groups of six animals each. Each animal received intramuscularly 5.0 mg kg-1 of BU or ST once a week for 4 weeks (P1); 2.5 mg kg-1 of BU or ST once a week for 8 weeks (P2); and 1.25 mg kg-1 of BU or ST once a week for 12 weeks (P3). For each protocol, a control group was used, and they received 0.1 ml of olive oil intramuscularly. Blood and fragments of liver and kidney were collected for alanine aminotransferase activity (ALT), alkaline phosphatase, albumin, creatinine, cholesterol, total protein, triglycerides, urea, reactive oxygen species, thiobarbituric acid reactive substances, total thiols, and glutathione evaluation. The results show that the BU in doses of 5 (day 30) and 2.5 mg kg-1 (day 60) changes the ALT seric activity, possibly showing a hepatotoxic effect. High doses of BU may lead to increased levels of cholesterol (protocol P1) possibly due to inhibition of the normal steroid biosynthesis process. All protocols used caused changes in the redox balance of the organs studied (except in the liver, protocol P2), which indicates that these drugs might be harmful even at low doses.


Assuntos
Rim/metabolismo , Fígado/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Congêneres da Testosterona/efeitos adversos , Congêneres da Testosterona/farmacologia , Animais , Biomarcadores/metabolismo , Rim/patologia , Fígado/patologia , Masculino , Ratos , Ratos Wistar
3.
Exp Parasitol ; 133(3): 357-64, 2013 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23270806

RESUMO

The aim of this study was to evaluate biochemical parameters of iron metabolism in rats experimentally infected with Trypanosoma evansi. To this end, 20 rats (Wistar) were intraperitoneally inoculated with blood containing trypomastigotes 10(6) (Group T) and 12 animals were used as negative control (Group C) and received saline (0.2 mL) through same route. Blood samples were collected by cardiac puncture on day 5 (C5, T5) and 30 (C30, T30) post-inoculation (pi) to perform complete blood count and determination of serum iron, transferrin, ferritin, total and latent iron fixation capacity, transferrin saturation and prohepcidin concentration. Also, bone marrow samples were collected, to perform Pearls staining reaction. Levels of iron, total and latent iron binding capacity and prohepcidin concentration were lower (P<0.05) in infected rats (T5 and T30 groups) compared to controls. On the other hand, levels of transferrin and ferritin were higher when compared to controls (P<0.05). The transferrin saturation increased on day 5 pi, but decreased on day 30 pi. The Pearls reaction showed a higher accumulation of iron in the bone marrow of infected animals in day 5 pi (P<0.01). Infection with T. evansi in rats caused anemia and changes in iron metabolism associated to the peaks of parasitemia. These results suggest that changes in iron metabolism may be related to the host immune response to infection and anemic status of infected animals.


Assuntos
Ferro/metabolismo , Tripanossomíase/metabolismo , Anemia Ferropriva/imunologia , Anemia Ferropriva/parasitologia , Animais , Peptídeos Catiônicos Antimicrobianos/sangue , Medula Óssea/metabolismo , Cães , Contagem de Eritrócitos , Índices de Eritrócitos , Ferritinas/metabolismo , Hematócrito , Hemoglobinas/análise , Hemossiderina/metabolismo , Hepcidinas , Sistema Imunitário/metabolismo , Ferro/sangue , Masculino , Parasitemia/imunologia , Parasitemia/parasitologia , Precursores de Proteínas/sangue , Ratos , Ratos Wistar , Transferrina/metabolismo , Trypanosoma/crescimento & desenvolvimento , Tripanossomíase/sangue , Tripanossomíase/complicações , Tripanossomíase/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA